ESC 365 - Activation of bone morphogenetic protein type 1A receptors (BMPR1A) by THR184 halts the progression of the left ventricular remodelling under pressure overload

CBS PREMIUM ACCESS

Activation of bone morphogenetic protein type 1A receptors (BMPR1A) by THR184 halts the progression of the left ventricular remodelling under pressure overload

Session: Moderated poster 4 AWARD

Topic: Drugs, Drug Targets

Speaker: Miss A. Salido Medina (Santander, ES)

Event: Frontiers in CardioVascular Biomedicine 2022

Congress Presentation

About the speaker

Miss Ana Belen Salido Medina

Instituto de Investigacion Sanitaria Valdecilla (IDIVAL), Santander (Spain)

0 follower

3 more presentations in this session

Mice deficient in endothelial cell-selective adhesion molecule develop left ventricle diastolic dysfunction

Speaker: Mr V. Buncha (Augusta, US)

Epigenetic regulation at LRP1 risk locus for cardiovascular diseases and assessment of cellular function in hiPSC derived smooth muscle cells

Speaker: Ms L. Liu (Paris, FR)

Single cell profiling of adipose tissue in atherosclerosis

Speaker: Doctor U. Thanigai Arasu (Kuopio, FI)

Access the full session

Moderated poster 4 AWARD

Speakers: Miss A. Salido Medina, Mr V. Buncha, Ms L. Liu, Doctor U. Thanigai Arasu

About the event

Frontiers in CardioVascular Biomedicine 2022

29 April - 1 May 2022

Sessions Presentations

Congress

ESC 365 is supported by